+1 877 705 1914• 24 / 7
HIPAA Compliant
ISO 27001 Certified

Actively Recruiting

Phase 2
Age: 40Years +
All Genders
ID05488431

Study of Bempedoic Acid to Reduce Cholesterol and Inflammation in People Living with HIV Phase 2 Randomized, Placebo-Controlled Trial in Adults Aged 40 and Older with Cardiovascular Disease or Risk Factors

Led by Priscilla Hsue, MD · Updated on 2025-12-17

121

Participants Needed

3

Research Sites

N/A

Total Duration

AI-Summary

What This Trial Is About

People living with HIV have a higher risk of heart disease and related complications. This research is a randomized, placebo-controlled trial studying Bempedoic acid BA, a drug that may reduce cholesterol and inflammation in HIV-infected individuals aged 40 and older who have known cardiovascular disease CVD or at least one risk factor for CVD. The trial aims to understand how BA affects arterial inflammation, lipid levels, immune activation, cardiometabolic health, and non-calcified plaque in the coronary arteries using advanced imaging techniques. Participants in this study are randomly assigned to receive either 180 mg of Bempedoic acid or a placebo once daily by mouth for 52 weeks. The trial includes multiple locations with specialized imaging performed at a core facility. The Bempedoic acid works by inhibiting an enzyme involved in cholesterol production and is being studied for its effects on lipid lowering, inflammation, and glucose metabolism in this population. During the study, participants will undergo several assessments including FDG-PETCT scans to measure arterial inflammation at the start and after 52 weeks. Blood tests will be performed at baseline, 24 weeks, and 52 weeks to monitor cholesterol types, blood sugar control, markers of inflammation, immune cell activation, and fat tissue volumes. Researchers will closely observe safety, treatment adherence, and the impact of BA on heart disease markers over the year-long study period.

CONDITIONS

Brief Title

Cholesterol and Inflammation Lowering Via Bempedoic Acid, an ACL-inhibiting Regimen in HIV Trial (CLEAR HIV Trial)

Research Team

M

Marta Levkova

Not the Right Trial for You?

Explore thousands of other clinical trials that might be a better match.
Sign up to get personalized trial recommendations delivered to your inbox.

Already have an account? Log in here